Stefan Flasche

1992–2025 年に発表

99
論文数
20,770
被引用数
49
h 指数
91
i10 指数

被引用数

Stefan Flasche の年別被引用数1990 年: 被引用 1 件1992 年: 被引用 1 件1997 年: 被引用 2 件1998 年: 被引用 1 件2000 年: 被引用 1 件2002 年: 被引用 1 件2004 年: 被引用 5 件2005 年: 被引用 1 件2007 年: 被引用 2 件2009 年: 被引用 1 件2010 年: 被引用 8 件2011 年: 被引用 16 件2012 年: 被引用 26 件2013 年: 被引用 10 件2014 年: 被引用 18 件2015 年: 被引用 24 件2016 年: 被引用 34 件2017 年: 被引用 38 件2018 年: 被引用 32 件2019 年: 被引用 170 件2020 年: 被引用 2,499 件2021 年: 被引用 2,285 件2022 年: 被引用 904 件2023 年: 被引用 433 件2024 年: 被引用 488 件2025 年: 被引用 232 件2026 年: 被引用 17 件1991 年は被引用が無いため表示していません1993〜1996 年は被引用が無いため表示していません1999 年は被引用が無いため表示していません2001 年は被引用が無いため表示していません2003 年は被引用が無いため表示していません2006 年は被引用が無いため表示していません2008 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,970 件、この内訳の 17.3%イギリス: 引用元論文 1,403 件、この内訳の 12.4%中国: 引用元論文 745 件、この内訳の 6.6%イタリア: 引用元論文 406 件、この内訳の 3.6%オーストラリア: 引用元論文 389 件、この内訳の 3.4%インド: 引用元論文 356 件、この内訳の 3.1%ドイツ: 引用元論文 340 件、この内訳の 3%カナダ: 引用元論文 324 件、この内訳の 2.9%フランス: 引用元論文 323 件、この内訳の 2.8%スイス: 引用元論文 311 件、この内訳の 2.7%スペイン: 引用元論文 222 件、この内訳の 2%オランダ: 引用元論文 207 件、この内訳の 1.8%
0%17.3%その他 38.4%

分野

  • Medicine39.8%
  • Mathematics39.4%
  • Computer Science5%
  • Social Sciences3.9%
  • Psychology2.8%
  • Health Professions1.8%
  • その他7.3%

トピック

  • COVID-19 epidemiological studies18%
  • SARS-CoV-2 and COVID-19 Research8.5%
  • COVID-19 Clinical Research Studies5.1%
  • Viral Infections and Outbreaks Research3.5%
  • COVID-19 Pandemic Impacts3.3%
  • COVID-19 and Mental Health2.9%
  • その他58.7%

共著者

全論文

検索で開く
  1. Age-dependent effects in the transmission and control of COVID-19 epidemics

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2020 被引用: 1,860

  2. Early dynamics of transmission and control of COVID-19: a mathematical modelling study

    著者: , , , , , , , , , , , , , , , , , , , , , - The Lancet Infectious Diseases 2020 被引用: 2,664

  3. Effectiveness of isolation, testing, contact tracing, and physical distancing on reducing transmission of SARS-CoV-2 in different settings: a mathematical modelling study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kiesha Prem, Stefan Flasche, Carl A. B. Pearson, Rein M G J Houben, Emily Nightingale, Akira Endo, Damien C. Tully, Yang Liu, Julian Villabona-Arenas, Kathleen O’Reilly, Sebastian Funk, Rosalind M. Eggo, Mark Jit, Eleanor M. Rees, Joel Hellewell, Samuel Clifford, Christopher I Jarvis, Sam Abbott, Megan Auzenbergs, Nicholas G. Davies, David Simons - The Lancet Infectious Diseases 2020 被引用: 958

  4. The effect of control strategies to reduce social mixing on outcomes of the COVID-19 epidemic in Wuhan, China: a modelling study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Public Health 2020 被引用: 2,315

  5. Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts

    著者: , , , , , , , , , , , , , , , , , , , , , - The Lancet Global Health 2020 被引用: 2,826

  6. Measuring the effects of COVID-19-related disruption on dengue transmission in southeast Asia and Latin America: a statistical modelling study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Hamish P Gibbs, Lloyd A C Chapman, Katherine E. Atkins, David Hodgson, Rosanna C Barnard, Timothy W Russell, Petra Klepac, Yalda Jafari, Rosalind M Eggo, Paul Mee, Matthew Quaife, Akira Endo, Sebastian Funk, Stéphane Hué, Adam J Kucharski, W John Edmunds, Kathleen O'Reilly, Rachael Pung, C Julian Villabona-Arenas, Amy Gimma, Kaja Abbas, Kiesha Prem, Gwenan M Knight, Fiona Yueqian Sun, William Waites, James D Munday, Mihaly Koltai, Frank G Sandmann, Damien C Tully - The Lancet Infectious Diseases 2022 被引用: 155

  7. Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Graham F. Medley, Gwen Knight, James D Munday, Adam J. Kucharski, Carl A. B. Pearson, Petra Klepac, Kiesha Prem, Rein M G J Houben, Akira Endo, Stefan Flasche, Nicholas G. Davies, Charlie Diamond, Kevin van Zandvoort, Sebastian Funk, Megan Auzenbergs, Eleanor M. Rees, Damien C. Tully, Jon C. Emery, Billy J. Quilty, Sam Abbott, Christian Julián Villabona‐Arenas, Stéphane Hué, Joel Hellewell, Amy Gimma, Christopher I Jarvis - The Lancet Global Health 2020 被引用: 1,231

  8. Protecting infants against RSV disease: an impact and cost-effectiveness comparison of long-acting monoclonal antibodies and maternal vaccination

    著者: , , , , , , , - The Lancet Regional Health - Europe 2024 被引用: 66

  9. Deliberations of the Strategic Advisory Group of Experts on Immunization on the use of CYD-TDV dengue vaccine

    著者: , , , , , , , , , , , , , , , , , - The Lancet Infectious Diseases 2018 被引用: 169

  10. Effects of non-pharmaceutical interventions on COVID-19 cases, deaths, and demand for hospital services in the UK: a modelling study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , James D Munday, Alicia Roselló, Megan Auzenbergs, Gwen Knight, Rein M G J Houben, Yang Liu - The Lancet Public Health 2020 被引用: 975

  11. Using a real-world network to model localized COVID-19 control strategies

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Rein M G J Houben, Gwenan M. Knight, Sam Abbott, Fiona Yueqian Sun, Rachel Lowe, Damien C. Tully, Simon R. Procter, Christopher I Jarvis, Akira Endo, Kathleen O’Reilly, Jon C. Emery, Thibaut Jombart, Alicia Roselló, Arminder Deol, Matthew Quaife, Stéphane Hué, Yang Liu, Rosalind M. Eggo, Carl A. B. Pearson, Adam J. Kucharski, Lewis G. Spurgin - Nature Medicine 2020 被引用: 276

  12. Public health impact and cost-effectiveness of the RTS,S/AS01 malaria vaccine: a systematic comparison of predictions from four mathematical models

    著者: , , , , , , , , , , , , , , , - The Lancet 2015 被引用: 246

  13. Quarantine and testing strategies in contact tracing for SARS-CoV-2: a modelling study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jack Williams, Damien C. Tully, Stefan Flasche, Sophie Meakin, Kevin van Zandvoort, Fiona Yueqian Sun, Mark Jit, Petra Klepac, Matthew Quaife, Rosalind M. Eggo, Frank Sandmann, Akira Endo, Kiesha Prem, Sam Abbott, Rosanna C. Barnard, Yung-Wai D Chan, Megan Auzenbergs, Amy Gimma, Christian Julián Villabona‐Arenas, Nicholas G. Davies - The Lancet Public Health 2021 被引用: 240

  14. Estimating the time-varying reproduction number of SARS-CoV-2 using national and subnational case counts

    著者: , , , , , , , , , , , , , , , , , , , , , - Wellcome Open Research 2020 被引用: 286

  15. The Long-Term Safety, Public Health Impact, and Cost-Effectiveness of Routine Vaccination with a Recombinant, Live-Attenuated Dengue Vaccine (Dengvaxia): A Model Comparison Study

    著者: , , , , , , , , , , , , , , , , , , , , - PLoS Medicine 2016 被引用: 235

  16. The potential health and economic value of SARS-CoV-2 vaccination alongside physical distancing in the UK: a transmission model-based future scenario analysis and economic evaluation

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Charlie Diamond, Timothy Russell, Graham F. Medley, Stefan Flasche, Katherine E. Atkins, Kiesha Prem, David Simons, Megan Auzenbergs, Damien C. Tully, Christopher I Jarvis, Kevin van Zandvoort, Sam Abbott, Carl A. B. Pearson, Thibaut Jombart, Sophie Meakin, Anna M. Foss, Adam J. Kucharski, Billy J. Quilty, Hamish Gibbs, Samuel Clifford, Petra Klepac - The Lancet Infectious Diseases 2021 被引用: 193

  17. Effect and cost-effectiveness of pneumococcal conjugate vaccination: a global modelling analysis

    著者: , , , , , , - The Lancet Global Health 2018 被引用: 121

  18. Determinants of RSV epidemiology following suppression through pandemic contact restrictions

    著者: , , , , , , - Epidemics 2022 被引用: 52

  19. Estimating the cost-effectiveness of maternal vaccination and monoclonal antibodies for respiratory syncytial virus in Kenya and South Africa

    著者: , , , , , , , , , , , , , - BMC Medicine 2023 被引用: 31

  20. Routine childhood immunisation during the COVID-19 pandemic in Africa: a benefit–risk analysis of health benefits versus excess risk of SARS-CoV-2 infection

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Yang Liu, Akira Endo, Arminder Deol, Adam J. Kucharski, Sam Abbott, Christopher I Jarvis, Kathleen O’Reilly, Thibaut Jombart, Amy Gimma, Nikos I Bosse, Kiesha Prem, Stéphane Hué, Nicholas G. Davies, Rosalind M. Eggo, Samuel Clifford, Graham F. Medley - The Lancet Global Health 2020 被引用: 373

  21. Reconstructing the early global dynamics of under-ascertained COVID-19 cases and infections

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , James W. Rudge, Katherine E. Atkins, Megan Auzenbergs, Stefan Flasche, Rein M G J Houben, Billy J. Quilty, Petra Klepac, Matthew Quaife, Sebastian Funk, Quentin J. Leclerc, Jon C. Emery, Mark Jit, David Simons, Nikos I Bosse, Simon R. Procter, Fiona Yueqian Sun, Samuel Clifford, Katharine Sherratt, Alicia Roselló, Nicholas G. Davies, Oliver J. Brady, Damien C. Tully, Georgia R. Gore‐Langton - BMC Medicine 2020 被引用: 217

  22. Efficacy of live oral rotavirus vaccines by duration of follow-up: a meta-regression of randomised controlled trials

    著者: , , , , , , , - The Lancet Infectious Diseases 2019 被引用: 124

  23. Within-host dynamics shape antibiotic resistance in commensal bacteria

    著者: , , , - Nature Ecology & Evolution 2019 被引用: 109

  24. Optimal Respiratory Syncytial Virus intervention programmes using Nirsevimab in England and Wales

    著者: , , , , , - Vaccine 2022 被引用: 32